GENES TO THERAPIES holds 1 USPTO trademark filings across 0 NICE classes. The largest concentration is in Class 35 (Advertising & Business) with 1 filings. The WikiTrademarks Expansion Score is 4/100, low — the brand is focused on defending its existing categories rather than expanding.
USPTO data refreshed August 19, 2026
Protect or track "GENES TO THERAPIES"
Watch this name and we'll alert you when anyone files a similar mark.
Informational only, not a legal opinion. Consult a trademark attorney before filing or enforcing.
Own this brand? Claim the profile to add your logo, story, and website.
Sign in to claimHow is GENES TO THERAPIES filing trademarks, and where is the portfolio expanding?
Filing Velocity (24 Months)
Nice Class Distribution
Activity Timeline
No activity recorded yet.
Recent Filings
| Serial No. | Mark | Filing Date | Status | Classes | Owner |
|---|---|---|---|---|---|
| 87761023 | GENES TO THERAPIES | Jan 18, 2018 | Pending | 035 Advertising & Business 036 Insurance & Finance 042 Science & Technology | Alzheimer's Disease Research Foundation |
Weekly visibility reports showing how ChatGPT mentions GENES TO THERAPIES, where you rank in the answer, the sentiment of the mention, and which sources ChatGPT cites.
FAQ: GENES TO THERAPIES trademark portfolio
What trademarks does GENES TO THERAPIES hold?
GENES TO THERAPIES holds 1 USPTO trademark filings across 0 NICE classes. The largest concentration is in Class 35 (Advertising & Business), Class 36 (Insurance & Finance), Class 42 (Science & Technology). The most recent filings are registered to Alzheimer's Disease Research Foundation.
How many trademarks does GENES TO THERAPIES have at the USPTO?
WikiTrademarks tracks 1 USPTO trademark filings attributed to GENES TO THERAPIES. The brand has been actively filing since January 2018. The count updates daily as new filings are indexed from the USPTO bulk data feed.
In which NICE classes does GENES TO THERAPIES file most often?
GENES TO THERAPIES's most active class is NICE Class 35 (Advertising & Business), with 1 filings. The full distribution across all 0 classes is shown in the Nice Class Distribution panel on this page.
Who owns the GENES TO THERAPIES trademark?
The most recent filings under the GENES TO THERAPIES mark are registered to Alzheimer's Disease Research Foundation. Trademark ownership can shift through assignments — see the Ownership & Assignment History section on this page for the full chain of title.
Is GENES TO THERAPIES expanding into new categories?
The current WikiTrademarks Expansion Score for GENES TO THERAPIES is 4 out of 100, which is low — the brand is focused on defending its existing categories rather than expanding. The score combines NICE class breadth, filing velocity, and the rate of cross-class movement from the brand's filing history.
How can I track new GENES TO THERAPIES trademark filings?
Click the Watch Brand button at the top of this page to add GENES TO THERAPIES to your Watchlist. New filings show up on your WikiTrademarks dashboard within 24 to 48 hours of being public, alongside any class expansions, status changes, or assignment events.
More on this portfolio: Compare GENES TO THERAPIES to another owner · Browse all NICE classes · Most valuable brands
Community notes
0 notesShare what you know about GENES TO THERAPIES and help the next person researching it.